Informed Consent for Expanded Access / Compassionate Use of an Investigational Drug

Technical Documentation & User Guide

ConsentCollect Medical Consent Builder

A comprehensive guide to utilizing the high-integrity builder for clinical consent documentation. Learn how to manage specialty templates, enforce forensic data integrity, and streamline surgical workflows.

1. Overview of the Builder

The ConsentCollect Medical Consent Builder is a specialized environment designed for the creation and management of high-stakes surgical consent documents. Unlike standard word processors, this builder enforces a structured data model that ensures every document remains compliant with hospital standards while providing the Forensic Informed Consent proof required in modern clinical risk management.

The builder operates on a modular "block" system. Every element, from the patient's personal info grid to the detailed Surgical Risk Disclosure, is treated as a discrete data point. This architecture allows for seamless portability between PDF exports and EHR-compatible JSON datasets.

2. Utilizing the Clinical Template Library

Efficiency in the clinical setting is paramount. The builder features an integrated Clinical Template Library that provides pre-validated starting points for various surgical specialties.

Accessing Templates

By clicking the "Templates" button in the header, users can access a searchable slide-over library. This library is categorized by specialty (e.g., Cardiology, Orthopedics, Gastroenterology). Each template is structured to include mandatory disclosures and specialty-specific risks.

  • Search and Filter: Use the search bar to locate specific procedures like "Pacemaker Insertion" or "Total Hip Arthroplasty."
  • Safe Loading: Loading a template will prompt a confirmation. This prevents accidental overwriting of current work while allowing for rapid context switching between different procedure forms.

These templates are designed to help providers answer the core question of clinical documentation: "How to automate patient risk disclosure in cardiology?" or other complex fields without sacrificing accuracy.

3. Modifying and Customizing Forms

The left panel of the builder is the primary workspace for customization. Here, users can modify the document's structure to match the specific needs of a patient or a facility.

Section Management

Every form is composed of several section types:

  • Text Blocks: Used for general disclosures, introductory text, and benefit summaries.
  • List Blocks: Specifically designed for risk disclosures where bulleted clarity is essential for patient comprehension.
  • Info Grids: Used for administrative data such as patient names, medical record numbers (MRN), and facility details.
  • Signature Blocks: Specialized areas for patient, physician, and witness verification.

Users can reorder sections using the "Up" and "Down" controls in the sidebar. This ensures that the flow of information follows the clinician's preferred disclosure sequence.

4. Managing Signatures and Verification

Digital Signature Integrity is the cornerstone of a defensible consent process. The builder provides dedicated fields for capturing the names of all participants in the informed consent discussion.

In the Medical Consent Builder, signature blocks are rendered with a specialized handwriting-style font in the preview and PDF export. This maintains the visual expectation of a clinical document while the underlying system handles the forensic timestamping and data coupling.

When configuring signature blocks, ensure that the "Label" field correctly identifies the role (e.g., "Attending Surgeon" vs. "Patient Representative") to comply with CMS Compliance Forms standards.

5. Secure Export and Data Portability

Once a form is prepared, it can be exported in two primary formats, each serving a different clinical or administrative purpose.

PDF Document Generation

The "Download PDF" feature generates a high-fidelity, archival-grade document. This document is formatted for clarity, utilizing a 2-column signature grid and specialized fonts to signal authority. These PDFs are intended for the permanent medical record and provide a physical backup of the digital interaction.

JSON Data Export (The Forensic Layer)

Clinicians often ask: "Can I export medical consent forms as validated JSON?" The answer is yes. The "Export JSON" feature provides a cryptographic backup of the form's state.

This file includes:

  • Metadata: Export source, version, and timestamp.
  • SHA-256 Checksum: A unique digital fingerprint that prevents unauthorized tampering.
  • Structured Content: Every section and field value in a machine-readable format.

6. Secure Import and File Verification

To reload a previously saved session or a standardized facility template, use the "Import" function. This process includes several automatic security checks to maintain Forensic Informed Consent standards.

When a file is uploaded, the builder:

  1. Verifies the metadata to ensure the file originated from a trusted ConsentCollect source.
  2. Recalculates the SHA-256 checksum against the current file content.
  3. Alerts the user if a mismatch is detected, indicating potential file corruption or manual tampering.

This rigorous process ensures that the Digital Signature Integrity is never compromised when moving files between systems or clinics.

7. Local Storage and Draft Recovery

The builder is designed to be resilient to browser refreshes or accidental tab closures. It utilizes the browser's `localStorage` to maintain a real-time draft of your work.

How it works:

  • Continuous Sync: As you type, the form state is serialized and stored under the key `cc_builder_draft`.
  • Restore Prompt: If you return to the builder after a closure, the system detects the existing draft and provides a "Restore" or "Discard" prompt.
  • Safety Guard: The system automatically pauses autosaving while the restore prompt is visible, ensuring that a fresh page load doesn't overwrite your valuable unsaved work.

8. Compliance with Professional Standards

Administrators often need to know: "How to create a TJC compliant consent form?" The builder facilitates this by providing the structure necessary for Joint Commission and CMS audits.

By utilizing CMS Compliance Forms standards, the builder ensures that every document includes the "Big Three" of informed consent:

  1. Nature of the Procedure: Clear titles and descriptions.
  2. Risks and Benefits: Structured lists that patients can easily read.
  3. Verification: Contemporaneous signing by the provider and patient.

Furthermore, the EHR Integrated Consent capabilities allow these documents to be pushed into any FHIR R4-compliant system, maintaining a single source of truth for the patient's care journey.

Frequently Asked Questions

Is the Medical Consent Builder free or paid?

This builder is always and forever free for all clinical users.

Does it have pre-formatted consent form templates?

Yes, you can quickly access hundreds of clinical consent forms with search for your specialty through our integrated library.

Can I customise the forms anyway I want?

Yes absolutely, you have complete control on every element of the consent form editor including sections, fields, and signature blocks.

Does it have premium features too?

This builder is always free. For professional-grade clinical integration, our platform includes:

  • Adaptive AI Form Builder (Digitalizing legacy paper forms)
  • Patient Comprehension Engine (Automated 6th-grade summaries)
  • FHIR R4 Validated Export (Direct EHR integration)
  • Context-Aware Engine (Regional legal adaptation)
  • Immutable Audit Engine (Malpractice defense logs)
  • Multilingual Consent (Spanish, Arabic, French support)
  • Automated Follow-ups (SMS and Email reminders)
  • Longitudinal Tracking (Care journey history)
  • Intelligent Template Library (Clinical guideline suggestions)

These features are fully active. Get started now to access professional-grade features.

Are the free forms and templates fully compliant and can be used in real?

Absolutely. However, we strongly recommend to customise every template according to your region, client, and specific clinical use cases to ensure absolute legal and clinical accuracy.

Forensic Standard

All builder exports include SHA-256 validation to ensure document integrity in legal proceedings.

Section 1info grid
Section 2text block
Section 3list block
Section 4list block
Section 5text block
Section 6list block
Section 7text block
Section 8list block
Section 9text block
Section 10text block
Section 11text block
Section 12text block
Section 13text block
Section 14text block
Section 15signature block
ConsentCollect Logo

Informed Consent for Expanded Access / Compassionate Use of an Investigational Drug

Comprehensive clinical-grade consent form layout for expanded access (compassionate use) pathways, covering FDA regulatory status, efficacy uncertainties, potential toxicities, and cost/billing exclusions.

Patient and Investigational Product Information

1. Nature and Purpose of Expanded Access

Expanded access, also known as compassionate use, is a regulatory pathway that allows patients with serious, immediately life-threatening, or advanced conditions to receive investigational medical products (drugs, biologics, or medical devices) outside of clinical trials when no comparable alternative therapy options exist. An investigational product is one that has not yet been approved by the FDA for general sale. Your physician has determined that you meet the strict criteria for expanded access and has obtained specific approval from both the drug manufacturer and the FDA to prescribe this investigational product to you.

2. FDA Regulatory Status and Efficacy Disclosures

The investigational product listed above has NOT been approved by the FDA as safe or effective for treating your condition.
The drug is still undergoing clinical testing in other settings. There is no guarantee that the drug will shrink your tumor, slow your disease, or extend your life.
The optimal dose, schedule of administration, and long-term side effects are not fully established.

3. Material Risks and Potential Toxicities

Severe unknown toxicities: because this drug is still in development, you may experience severe, life-threatening, or fatal side effects that have never been reported before.
Allergic reactions: potential severe allergic reactions (anaphylaxis) during or after administration, causing drop in blood pressure, hives, or breathing difficulty.
Disease worsening: the drug could theoretically speed up the progression of your disease or make your symptoms worse.
Organ damage: potential damage to your liver, kidneys, heart, or bone marrow, requiring regular blood tests and monitoring.

4. Cost and Billing Exclusions

Standard health insurance plans (including Medicare and Medicaid) rarely cover the cost of investigational drugs or the clinic fees associated with administering them. I understand that: (1) The drug manufacturer may charge a fee for the drug under FDA regulations, which I will be responsible for if not covered by a specialized program. (2) I am responsible for all associated administration, lab, and hospital billing fees. (3) I agree to review my financial plan with the clinic's billing department before starting treatment.

5. Alternatives to Compassionate Use

Enrolling in a formal clinical trial for the same or a different investigational drug, if I meet the eligibility criteria.
Receiving standard supportive care (palliative care) to manage my symptoms and maximize my comfort, without active tumor-directed treatment.
No treatment: choosing not to receive any active or supportive interventions.

6. Monitoring and Safety Commitment

Receiving an investigational drug requires strict safety monitoring. You must attend all scheduled clinic visits, blood draws, and imaging scans (CT or MRI) to check for side effects and evaluate how your disease is responding. You must report any new symptoms, changes in medications, or visits to other doctors to your primary physician immediately.

7. Emergency Warning Signs

Difficulty breathing, shortness of breath, or swelling of the face, lips, or throat (signs of severe allergic reaction).
Fever above 100.4 degrees Fahrenheit (38 degrees Celsius) or chills.
Uncontrolled nausea, vomiting, or diarrhea that prevents you from keeping liquids down.
Sudden severe pain, bleeding, or bruising.

8. Right to Refuse or Stop Treatment

You have the right to refuse or stop the investigational treatment at any time. Stopping the drug will not affect your relationship with your doctors or your access to standard supportive care at this facility.

9. Data Collection and Reporting

Your physician is required to collect details about your treatment, side effects, and clinical outcomes and report them to the drug manufacturer and the FDA. Coded (de-identified) records will be used for these reports to protect your privacy.

10. Patient Understanding and Questions

I confirm that I have read this document and understand the expanded access/compassionate use program, the unproven efficacy of the drug, the risk of severe or unknown side effects, the financial exclusions, and the monitoring rules. All my questions have been answered.

11. Language Access Services

If English is not your primary language, a qualified interpreter is available at no cost. Please inform staff before signing.

12. Copy of Consent Acknowledgment

I acknowledge that I have been offered a copy of this signed consent form.

13. Patient Authorization

I voluntarily consent to receive the investigational drug under the FDA expanded access pathway. I authorize my physician to coordinate the drug delivery, administer the infusions, perform the safety monitoring, and report my de-identified data to the manufacturer and the FDA.

Signatures and Verification

Patient Signature (or LAR Signature)
Relationship (if signed by LAR)
Prescribing Physician Signature
Witness Signature
Date and Time of Consent
Document ID: CC-PENDING
POWERED BY CONSENTCOLLECT